A Study to Evaluate ART101 in Adult Participants With Hypertension

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a Phase 1, first-in-human, randomized, double-blind, placebo-controlled, study to assess the safety, tolerability, Pharmacokinetics (PK), and pharmacodynamics (PD) of a single dose of ART101 administered via subcutaneous injection to hypertensive adult participants. An anticipated 5 dose cohorts (one as optional) with maximum of 40 participants will be randomized in SAD study.
Epistemonikos ID: f75bf38e88c36af459260b84ec2486ca419dc9e3
First added on: Feb 01, 2025